Skip to main content

The vice president of scientific engagement at Alzheimer’s Association talked about the emergence of blood biomarker tests as valuable diagnostic tools for Alzheimer disease in the clinical setting. [WATCH TIME: 5 minutes]:

Source: Neurology Read More